Spinal pharmacology of tactile allodynia in diabetic rats.
about
Spinal cord stimulation in experimental chronic painful diabetic polyneuropathy: Delayed effect of High-frequency stimulation.Regulation of increased glutamatergic input to spinal dorsal horn neurons by mGluR5 in diabetic neuropathic pain.Increased presynaptic and postsynaptic α2-adrenoceptor activity in the spinal dorsal horn in painful diabetic neuropathy.Expression of alpha 1D subunit mRNA is correlated with L-type Ca2+ channel activity in single neurons of hippocampal "zipper" slicesInduction of spinal long-term synaptic potentiation is sensitive to inhibition of neuronal NOS in L5 spinal nerve-transected ratsA streptozotocin-induced diabetic neuropathic pain model for static or dynamic mechanical allodynia and vulvodynia: validation using topical and systemic gabapentinPGE2, Kidney Disease, and Cardiovascular Risk: Beyond Hypertension and Diabetes.Allodynia and hyperalgesia in diabetic rats are mediated by GABA and depletion of spinal potassium-chloride co-transporters.Endothelin receptors and painAntinociceptive effects of chronic administration of uncompetitive NMDA receptor antagonists in a rat model of diabetic neuropathic pain.Pulsed radiofrequency attenuates diabetic neuropathic pain and suppresses formalin-evoked spinal glutamate release in ratsBiochanin-A attenuates neuropathic pain in diabetic rats.Protective Effect of Agaricus brasiliensis on STZ-Induced Diabetic Neuropathic Pain in Rats.Altered rate-dependent depression of the spinal H-reflex as an indicator of spinal disinhibition in models of neuropathic painAbnormal calcium homeostasis in peripheral neuropathies.Calcium channel functions in pain processingPharmacological treatment of diabetic neuropathic pain.Targeting voltage-gated calcium channels: developments in peptide and small-molecule inhibitors for the treatment of neuropathic pain.Emblica officinalis corrects functional, biochemical and molecular deficits in experimental diabetic neuropathy by targeting the oxido-nitrosative stress mediated inflammatory cascade.Effect of resveratrol, a polyphenolic phytoalexin, on thermal hyperalgesia in a mouse model of diabetic neuropathic pain.Fosinopril Prevents the Development of Tactile Allodynia in a Streptozotocin-Induced Diabetic Rat Model.Similar pattern of peripheral neuropathy in mouse models of type 1 diabetes and Alzheimer's disease.Differential effects of voltage-gated calcium channel blockers on calcium channel alpha-2-delta-1 subunit protein-mediated nociceptionReduction by gabapentin of K+-evoked release of [3H]-glutamate from the caudal trigeminal nucleus of the streptozotocin-treated rat.Altered synaptic input and GABAB receptor function in spinal superficial dorsal horn neurons in rats with diabetic neuropathy.Participation of neuronal nitric oxide synthase in experimental neuropathic pain induced by sciatic nerve transection.Insulin implants prevent the temporal development of mechanical allodynia and opioid hyposensitivity for 24-wks in streptozotocin (STZ)-diabetic Wistar rats.Emerging drugs for neuropathic pain.Streptozotocin-induced mechanical hypernociception is not dependent on hyperglycemia.Gabapentin reverses microglial activation in the spinal cord of streptozotocin-induced diabetic rats.Plateau potential-dependent windup of the response to primary afferent stimuli in rat dorsal horn neurons.Longitudinal Study of Painful Diabetic Neuropathy in the Zucker Diabetic Fatty Rat Model of Type 2 Diabetes: Impaired Basal G-Protein Activity Appears to Underpin Marked Morphine Hyposensitivity at 6 Months
P2860
Q33626142-F462A96F-765F-48CF-85F4-79DB77D1D92BQ33978728-3935C307-3853-4148-80EF-D21AAC8195C5Q34715812-52D83AFB-8D05-4F38-A6FB-4C4D2DAF9214Q35682874-2FCA9669-2CC0-480F-BB50-261E6167370CQ35726847-F3327506-69DC-4E84-B35B-21A706826DEBQ36203460-C0EAE755-B12E-4135-AF35-C775DFE39B0DQ36624751-CA17C0E2-2F86-4DBA-BE0C-CB78E32DA8E4Q36995022-79B251C3-3DF7-4BE8-813C-6E51C5566225Q37070713-DDC0418C-8D98-4E07-B0AC-0EC6FB01FD0BQ37345125-2107CAE2-EFC7-436F-80FA-28767B8F232BQ37513484-8D76DA6D-CE0D-4228-8BE8-0A9662BE34F3Q37538895-2F3335D2-C768-4577-B719-055FE05E3DB4Q37554034-80896E0E-DECB-4CFC-85CB-9088CD72B139Q37625422-8DA364A2-D38D-45C0-BF15-DF15AAB053D2Q37662579-9FBE3B0D-CC94-4D7C-8AA1-D3E2F4512BEBQ37819805-CF4A0862-7D5E-48A0-B654-7E991517B45DQ37858519-C762BA34-46AE-4ED6-98E9-71D36CF6AA49Q38020929-A01E2593-AF34-44C6-A10C-116CEA6A939EQ39269541-C2C75957-EBC3-4547-9401-86F9DE62AB67Q39340989-F8B1390F-83FB-4BA8-BEA3-21DB583A0D33Q40562632-83AA540D-DF16-4FF0-8EEE-CFE3C882D762Q40746525-D24BFEBB-1E2B-4485-B547-F3424F00C818Q41902234-B533A319-23D7-43D5-8419-2EE79C5B458BQ42246215-29061A6C-13CC-4B89-B8F2-1C0AB95A426AQ42506713-4EFF3558-D1AF-49D4-B390-E1C38A937A83Q43072564-765F3CC8-649A-4E7D-91E5-D6FB85FA40F8Q44350262-7A422A97-124D-4B88-9316-D0F7A15C43E8Q46083475-64DC55E6-7D13-4025-AFBB-8A9CCD0EE883Q46093986-5D1B320D-4A72-4CFE-8736-B43489A0EC50Q46270029-C861A991-BA29-43A9-9487-4B75BF8D1CBFQ51379172-25409FFC-AA2B-4929-AB1C-FC09624FBE69Q58812772-2BBBC81A-0454-4025-9728-030A52AAF2B5
P2860
Spinal pharmacology of tactile allodynia in diabetic rats.
description
1997 nî lūn-bûn
@nan
1997 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
name
Spinal pharmacology of tactile allodynia in diabetic rats.
@ast
Spinal pharmacology of tactile allodynia in diabetic rats.
@en
type
label
Spinal pharmacology of tactile allodynia in diabetic rats.
@ast
Spinal pharmacology of tactile allodynia in diabetic rats.
@en
prefLabel
Spinal pharmacology of tactile allodynia in diabetic rats.
@ast
Spinal pharmacology of tactile allodynia in diabetic rats.
@en
P356
P1476
Spinal pharmacology of tactile allodynia in diabetic rats.
@en
P2093
N A Calcutt
S R Chaplan
P304
P356
10.1038/SJ.BJP.0701538
P407
P577
1997-12-01T00:00:00Z